NR4A1 and central nervous system cancer: An adverse effect on disease outcome during pregnancy has been observed in six of eight pregnancies in women with low grade gliomas followed by the French low grade glioma (LGG) group, possibly due to the decreased immune surveillance during pregnancy or to the presence of potential hormonal receptors on glioma cells4,16.